Latest Announcement

Compremium Corp. Receives FDA clearance for the CPMX1 System

Switzerland based Compremium Corp. announces U.S. Food and Drug Administration FDA510k market clearance of its Compartmental Compressibility Monitoring System CPMX1.
Read
Compremium Corp. Receives FDA clearance for the CPMX1 System
Read

Turning Point in Diagnostics

1 out of 2 people in the world have a diagnostic condition related to pressure — our breakthrough innovation is here to help.
GET STARTED
Be part of the change
CHALLENGE

Until now, our only options have been subjective, unspecific, or invasive

Palpation
A subjective and unreliable clinical assessment.
Imaging
Imaging techniques are unspecific and not actionable.
Invasive Devices
Poor patient experience and risk of infection.
Solution

A non-invasive platform technology for the diagnosis of pressure-related conditions

Learn about the solution
Our methodology

Founded on game-changing methods for objective, actionable data points

Compressibility

Measure of relative change in the depth of a compartment when external pressure is applied

Occlusion Pressure

Method of assessing pressure at the point of occlusion for any vessel of interest
Learn about the science

Scientific validation

40
+
Publications
100
+
Authors
400
+
Study participants
10
+
Anatomical structures
SEE  PUBLICATIONS

Latest news

See all posts

Important advancement in pediatric diagnostics

by compremium team

Clinical study with Compremium's non-invasive method on 25 pediatric patients suggests an easy and secure approach that has the potential to eliminate the need for invasive measurement of suspected Acute Compartment Syndrome (ACS).

Read

Compremium Corp. receives FDA clearance for the CPMX1 System

by compremium team

Switzerland based Compremium Corp. announces U.S. Food and Drug Administration (FDA) 510(k) market clearance of its Compartmental Compressibility Monitoring System CPMX1.

Read

Long term partnership with NASA for human advancement

by compremium team

NASA commits to Compremium’s CPMX1 System for deep space missions to Moon and Mars. The device will be used to ensure astronaut health during the long flights in zero gravity.

Read